National Institute on Drug Abuse; Notice of Closed Meeting

• Published date: 27 October 2020
• Citation: 85 FR 68083
• Record Number: 2020-23679
• Section: Notices
• Court: National Institutes Of Health

Federal Register, Volume 85 Issue 208 (Tuesday, October 27, 2020)

[Federal Register Volume 85, Number 208 (Tuesday, October 27, 2020)]
                [Notices]
                [Page 68083]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-23679]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Closed Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; Conflict SEP for NIDA-L.
                 Date: November 18, 2020.
                 Time: 11:00 a.m. to 12:30 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, National Institute on Drug
                Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual
                Meeting).
                 Contact Person: Sheila Pirooznia, Ph.D., Scientific Review
                Officer, Scientific Review Branch, Division of Extramural Review,
                National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
                MSC 6021, Bethesda, MD 20892, (301) 496-9350,
                [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
                Abuse Scientist Development Award for Clinicians, Scientist
                Development Awards, and Research Scientist Awards; 93.278, Drug
                Abuse National Research Service Awards for Research Training;
                93.279, Drug Abuse and Addiction Research Programs, National
                Institutes of Health, HHS)
                 Dated: October 21, 2020.
                Tyeshia M. Roberson,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2020-23679 Filed 10-26-20; 8:45 am]
                BILLING CODE 4140-01-P